Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

CXCR4-targeted sorafenib-loaded DOPA/TPGS-PLGA nanoparticles

Based on

1 Articles
2015 Most recent source

Composition

1

poly(lactic-co-glycolic acid)

PLGA
Type Polymer
Formula
Role core
2

D-α-tocopheryl polyethylene glycol 1000 succinate

TPGS
Type Polymer
Formula
Role layer
3

dioleoylphosphatidic acid

dioleoylphosphatydic acid DOPA
Type Single Compound
Formula C39H73O8P
Role layer
4

plerixafor

AMD3100
Type Single Compound
Formula C28H54N8
Role layer
5

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide

sorafenib SFN SOR SF
Type Single Compound
Formula C21H16ClF3N4O3
Role loaded material

Properties

General physical and chemical properties

Property Value Source

Full content is available to subscribers only

To view content please choose from the following:

Applications

Area Application Source

Full content is available to subscribers only

To view content please choose from the following:

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Biological system Test details Source

Full content is available to subscribers only

To view content please choose from the following:

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • D-α-tocopheryl polyethylene glycol 1000 succinate
  • dioleoylphosphatidic acid
  • 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide
See all (4)
  1. ZkFG
Product

CXCR4-targeted sorafenib-loaded DOPA/TPGS-PLGA nanoparticles

Method 2

Type: Physical formation
Source:
Product

CXCR4-targeted sorafenib-loaded DOPA/TPGS-PLGA nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial